Market Tracker

08/31 11:19am ET

PDL BioPharma Inc (NASDAQ:PDLI)

5.63
BATS BZX Real-Time Price
As of 11:18am ET
 -0.02 / -0.35%
Today’s Change
4.58
Today|||52-Week Range
10.26
-26.98%
Year-to-Date

Today’s Trading

Previous close5.65
Today’s open5.64
Day’s range5.59 - 5.68
Volume419,115
Average volume (3 months)2,541,083
Market cap$927.6M
Dividend yield10.69%
Data as of 11:04am ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+16.67%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.0
Price/Sales2.30
Price/Book1.99

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.25-0.92%
ITCIIntra-Cellular Thera...+0.51+1.89%
FLMLFlamel Technologies ...+0.40+1.82%
SUPNSupernus Pharmaceuti...+0.25+1.40%
Data as of 11:19am ET, 08/31/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)$0.61
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts